Su Li Chen - Net Worth and Insider Trading

Su Li Chen Net Worth

The estimated net worth of Su Li Chen is at least $1 Million dollars as of 2024-06-22. Su Li Chen is the Executives of Realcan Pharmaceutical Group Co Ltd and owns about 565,700 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) stock worth over $1 Million. Details can be seen in Su Li Chen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Su Li Chen has not made any transactions after 2018-11-29 and currently still holds the listed stock(s).

Transaction Summary of Su Li Chen

To

Su Li Chen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Su Li Chen owns 1 companies in total, including Realcan Pharmaceutical Group Co Ltd (SZSE:002589) .

Click here to see the complete history of Su Li Chen’s form 4 insider trades.

Insider Ownership Summary of Su Li Chen

Ticker Comapny Transaction Date Type of Owner
SZSE:002589 Realcan Pharmaceutical Group Co Ltd 2018-11-29 Executives

Su Li Chen Latest Holdings Summary

Su Li Chen currently owns a total of 1 stock. Su Li Chen owns 565,700 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) as of November 29, 2018, with a value of $1 Million.

Latest Holdings of Su Li Chen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002589 Realcan Pharmaceutical Group Co Ltd 2018-11-29 565,700 2.28 1,289,796

Holding Weightings of Su Li Chen


Su Li Chen Form 4 Trading Tracker

According to the SEC Form 4 filings, Su Li Chen has made a total of 0 transactions in Realcan Pharmaceutical Group Co Ltd (SZSE:002589) over the past 5 years. The most-recent trade in Realcan Pharmaceutical Group Co Ltd is the acquisition of 100,700 shares on November 29, 2018, which cost Su Li Chen around $810,635.

Insider Trading History of Su Li Chen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Su Li Chen Trading Performance

GuruFocus tracks the stock performance after each of Su Li Chen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Su Li Chen is -22.37%. GuruFocus also compares Su Li Chen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Su Li Chen within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Su Li Chen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Su Li Chen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -13.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Su Li Chen Ownership Network

Ownership Network List of Su Li Chen

No Data

Ownership Network Relation of Su Li Chen

Insider Network Chart

Su Li Chen Owned Company Details

What does Realcan Pharmaceutical Group Co Ltd do?

Who are the key executives at Realcan Pharmaceutical Group Co Ltd?

Su Li Chen is the Executives of Realcan Pharmaceutical Group Co Ltd. Other key executives at Realcan Pharmaceutical Group Co Ltd include Directors & executives Zhang Ren Hua , Directors & Directors & and Executives Zhou Yun , and Executives Wu Di .

Realcan Pharmaceutical Group Co Ltd (SZSE:002589) Insider Trades Summary

Over the past 18 months, Su Li Chen made no insider transaction in Realcan Pharmaceutical Group Co Ltd (SZSE:002589). Other recent insider transactions involving Realcan Pharmaceutical Group Co Ltd (SZSE:002589) include a net sale of 0 shares made by Zhang Ren Hua , and a net sale of 2,000,000 shares made by Han Xu .

In summary, during the past 3 months, insiders sold 0 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,000,000 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,000,000 shares.

Realcan Pharmaceutical Group Co Ltd (SZSE:002589)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Realcan Pharmaceutical Group Co Ltd Insider Transactions

No Available Data

Su Li Chen Mailing Address

Above is the net worth, insider trading, and ownership report for Su Li Chen. Currently GuruFocus does not have mailing address information for Su Li Chen.

Discussions on Su Li Chen

No discussions yet.